AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 237 filers reported holding AMICUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,128,000 | -15.3% | 175,000 | -12.5% | 0.70% | -15.6% |
| Q2 2023 | $2,512,000 | -52.3% | 200,000 | -57.9% | 0.83% | -46.8% |
| Q1 2023 | $5,268,000 | +0.9% | 475,000 | -5.0% | 1.56% | +6.3% |
| Q3 2022 | $5,220,000 | -51.4% | 500,000 | -50.0% | 1.46% | -73.8% |
| Q2 2022 | $10,740,000 | +3.1% | 1,000,000 | -9.1% | 5.59% | +147.4% |
| Q1 2022 | $10,417,000 | +80.4% | 1,100,000 | +120.0% | 2.26% | +9.2% |
| Q4 2021 | $5,775,000 | +128.2% | 500,000 | +88.7% | 2.07% | +179.7% |
| Q3 2021 | $2,531,000 | -0.9% | 265,000 | 0.0% | 0.74% | +5.4% |
| Q2 2021 | $2,555,000 | -2.4% | 265,000 | 0.0% | 0.70% | +14.1% |
| Q1 2021 | $2,618,000 | -81.1% | 265,000 | -55.8% | 0.62% | -80.1% |
| Q4 2020 | $13,854,000 | +63.5% | 600,000 | 0.0% | 3.09% | +26.1% |
| Q3 2020 | $8,472,000 | -30.4% | 600,000 | -52.0% | 2.45% | +5.6% |
| Q4 2019 | $12,175,000 | -11.0% | 1,250,000 | -26.7% | 2.32% | -33.4% |
| Q3 2019 | $13,674,000 | -24.4% | 1,705,000 | +17.6% | 3.48% | -7.2% |
| Q2 2019 | $18,096,000 | +2.4% | 1,450,000 | +11.5% | 3.75% | -18.7% |
| Q1 2019 | $17,680,000 | +183.9% | 1,300,000 | +100.0% | 4.62% | +104.4% |
| Q4 2018 | $6,227,000 | -44.8% | 650,000 | -13.3% | 2.26% | -1.0% |
| Q1 2018 | $11,280,000 | +274.0% | 750,000 | +275.0% | 2.28% | +256.6% |
| Q3 2017 | $3,016,000 | +210.9% | 200,000 | +100.0% | 0.64% | +61.2% |
| Q4 2015 | $970,000 | -81.7% | 100,000 | -73.3% | 0.40% | -76.9% |
| Q2 2015 | $5,306,000 | -30.3% | 375,000 | -46.4% | 1.72% | +25.6% |
| Q1 2015 | $7,616,000 | +205.1% | 700,000 | +133.3% | 1.37% | +14.3% |
| Q4 2014 | $2,496,000 | +24.6% | 300,000 | -50.0% | 1.20% | -15.2% |
| Q2 2014 | $2,004,000 | – | 600,000 | – | 1.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |